15:45 EST Kazia Therapeutics (KZIA) trading halted, volatility trading pause
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KZIA:
- Kazia Therapeutics regains Nasdaq compliance
- Kazia Therapeutics files to sell 10.7M American depositary shares for holders
- Kazia Therapeutics Retains Nasdaq Listing After Regaining Compliance
- Kazia Therapeutics price target raised to $18 from $13 at H.C. Wainwright
- Kazia Therapeutics Unveils Promising Paxalisib Data at Breast Cancer Symposium